vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Urban Edge Properties (UE). Click either name above to swap in a different company.

Urban Edge Properties is the larger business by last-quarter revenue ($132.6M vs $75.1M, roughly 1.8× MEDIFAST INC). On growth, Urban Edge Properties posted the faster year-over-year revenue change (12.2% vs -36.9%). Over the past eight quarters, Urban Edge Properties's revenue compounded faster (11.6% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.

MED vs UE — Head-to-Head

Bigger by revenue
UE
UE
1.8× larger
UE
$132.6M
$75.1M
MED
Growing faster (revenue YoY)
UE
UE
+49.1% gap
UE
12.2%
-36.9%
MED
Faster 2-yr revenue CAGR
UE
UE
Annualised
UE
11.6%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
UE
UE
Revenue
$75.1M
$132.6M
Net Profit
$22.6M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
17.1%
Revenue YoY
-36.9%
12.2%
Net Profit YoY
-6.7%
EPS (diluted)
$-1.64
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
UE
UE
Q1 26
$132.6M
Q4 25
$75.1M
$119.6M
Q3 25
$89.4M
$120.1M
Q2 25
$105.6M
$114.1M
Q1 25
$115.7M
$118.2M
Q4 24
$119.0M
$116.4M
Q3 24
$140.2M
$112.4M
Q2 24
$168.6M
$106.5M
Net Profit
MED
MED
UE
UE
Q1 26
$22.6M
Q4 25
$12.4M
Q3 25
$-2.3M
$14.9M
Q2 25
$2.5M
$58.0M
Q1 25
$-772.0K
$8.2M
Q4 24
$30.1M
Q3 24
$1.1M
$9.1M
Q2 24
$-8.2M
$30.8M
Gross Margin
MED
MED
UE
UE
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
MED
MED
UE
UE
Q1 26
Q4 25
-10.4%
11.3%
Q3 25
-4.6%
13.4%
Q2 25
-1.0%
53.9%
Q1 25
-1.1%
7.6%
Q4 24
0.6%
27.6%
Q3 24
1.5%
8.9%
Q2 24
-4.7%
30.6%
Net Margin
MED
MED
UE
UE
Q1 26
17.1%
Q4 25
10.4%
Q3 25
-2.5%
12.4%
Q2 25
2.3%
50.8%
Q1 25
-0.7%
6.9%
Q4 24
25.9%
Q3 24
0.8%
8.1%
Q2 24
-4.8%
28.9%
EPS (diluted)
MED
MED
UE
UE
Q1 26
$0.18
Q4 25
$-1.64
$0.09
Q3 25
$-0.21
$0.12
Q2 25
$0.22
$0.46
Q1 25
$-0.07
$0.07
Q4 24
$0.08
$0.25
Q3 24
$0.10
$0.07
Q2 24
$-0.75
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
UE
UE
Cash + ST InvestmentsLiquidity on hand
$167.3M
$50.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$1.4B
Total Assets
$248.0M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
UE
UE
Q1 26
$50.0M
Q4 25
$167.3M
$48.9M
Q3 25
$173.5M
$77.8M
Q2 25
$162.7M
$53.0M
Q1 25
$164.6M
$48.0M
Q4 24
$162.3M
$41.4M
Q3 24
$170.0M
$67.9M
Q2 24
$163.5M
$78.6M
Stockholders' Equity
MED
MED
UE
UE
Q1 26
$1.4B
Q4 25
$198.9M
$1.4B
Q3 25
$214.7M
$1.4B
Q2 25
$216.0M
$1.4B
Q1 25
$211.0M
$1.4B
Q4 24
$210.1M
$1.4B
Q3 24
$207.3M
$1.3B
Q2 24
$205.3M
$1.3B
Total Assets
MED
MED
UE
UE
Q1 26
$3.4B
Q4 25
$248.0M
$3.3B
Q3 25
$268.2M
$3.3B
Q2 25
$269.3M
$3.3B
Q1 25
$280.0M
$3.3B
Q4 24
$284.2M
$3.3B
Q3 24
$291.2M
$3.2B
Q2 24
$293.5M
$3.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
UE
UE
Operating Cash FlowLast quarter
$-5.3M
$39.1M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
1.5%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
UE
UE
Q1 26
$39.1M
Q4 25
$-5.3M
$182.7M
Q3 25
$12.1M
$55.7M
Q2 25
$-3.4M
$43.5M
Q1 25
$3.4M
$32.6M
Q4 24
$-4.9M
$153.2M
Q3 24
$9.1M
$36.6M
Q2 24
$13.1M
$41.2M
Free Cash Flow
MED
MED
UE
UE
Q1 26
Q4 25
$-6.6M
$81.8M
Q3 25
$10.8M
$26.1M
Q2 25
$-4.8M
$19.6M
Q1 25
$1.9M
$11.9M
Q4 24
$-7.2M
$42.5M
Q3 24
$7.7M
$12.2M
Q2 24
$11.1M
$19.9M
FCF Margin
MED
MED
UE
UE
Q1 26
Q4 25
-8.8%
68.4%
Q3 25
12.0%
21.7%
Q2 25
-4.5%
17.2%
Q1 25
1.6%
10.0%
Q4 24
-6.1%
36.6%
Q3 24
5.5%
10.8%
Q2 24
6.6%
18.6%
Capex Intensity
MED
MED
UE
UE
Q1 26
1.5%
Q4 25
1.8%
84.4%
Q3 25
1.5%
24.6%
Q2 25
1.3%
20.9%
Q1 25
1.3%
17.5%
Q4 24
1.9%
95.1%
Q3 24
1.0%
21.7%
Q2 24
1.1%
20.1%
Cash Conversion
MED
MED
UE
UE
Q1 26
1.73×
Q4 25
14.71×
Q3 25
3.73×
Q2 25
-1.36×
0.75×
Q1 25
3.97×
Q4 24
5.09×
Q3 24
8.04×
4.03×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

UE
UE

Rental revenue$124.2M94%
Other$8.4M6%

Related Comparisons